Tweet
Following vaccination with Pandemrix has so far reported 23 cases of narcolepsy to the Norwegian Medicines Agency, 19 children and four adults. Public Health takes very seriously reports from Finland, Sweden and Norway on a possible link between Pandemrix-vaccination against influenza A (H1N1) and narcolepsy in children. We still ask health professionals report cases of narcolepsy after vaccination with Pandemrix. Public Health convey all information to the Medicines Agency, which together with its sister organizations in Europe.
Several studies are ongoing in Norway to survey the situation as best as possible. Norwegian health authorities cooperate with the European Scientific Committee for Medicinal Products (CHMP) to find out more about the relationship between the use of pandemic vaccine and the incidence of side effects. - Serious adverse events after vaccination is extremely rare. Rare side effects can only be detected when very many are vaccinated.
This is included in the overall assessment as new vaccines are used, and there will also be included in patient information, says Geir Stene-Larsen at Folkehelseinstituttet.I Norway has pandemic vaccination with Pandemrix helped to prevent disease and death in both 2009 and in 2010-11. The vaccine is not used now.
Several studies are ongoing in Norway to survey the situation as best as possible. Norwegian health authorities cooperate with the European Scientific Committee for Medicinal Products (CHMP) to find out more about the relationship between the use of pandemic vaccine and the incidence of side effects. - Serious adverse events after vaccination is extremely rare. Rare side effects can only be detected when very many are vaccinated.
This is included in the overall assessment as new vaccines are used, and there will also be included in patient information, says Geir Stene-Larsen at Folkehelseinstituttet.I Norway has pandemic vaccination with Pandemrix helped to prevent disease and death in both 2009 and in 2010-11. The vaccine is not used now.
